Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers.

Pharmacogenomics - 1 Jan 2025

Strother Ashton, Park Jeong M, Pasternak Amy L

Abstract excerpt

INTRODUCTION: Genotype-guided tacrolimus management is not routine in clinical practice despite the availability of Clinical Pharmacogenetics Implementation Consortium dosing guidelines. Prior surveys have evaluated patient and provider perspectives of pharmacogenetics (PGx) in transplant, but limited recent data exists on tacrolimus PGx implementation across United States transplant centers. METHODS: An...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Immunosuppressive Agents
Share to Organ Transplantation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Surveys and Questionnaires

Share to Tacrolimus

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 40205800
DOI: 10.1080/14622416.2025.2489920
PMCID: PMC12164375

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers.PMID 40205800Read ↗

Implementation of Clinical Cytochrome P450 3A Genotyping for Tacrolimus Dosing in a Large Kidney Transplant Program.Semantic proximity Read ↗

Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data.Semantic proximity Read ↗

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.Semantic proximity Read ↗

Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation.Semantic proximity Read ↗

Assessing the Utility of a Genotype-Guided Tacrolimus Equation in African American Kidney Transplant Recipients: A Single Institution Retrospective Study.Semantic proximity Read ↗

Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial.Semantic proximity Read ↗

Individualization of immunosuppression: concepts and rationale.Semantic proximity Read ↗

Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned.Semantic proximity Read ↗

A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation.Semantic proximity Read ↗

Practicability of pharmacogenetics in transplantation medicine.Semantic proximity Read ↗

Characterizing Pharmacogenetic Testing Among Children’s HospitalsSemantic proximity Read ↗

CYP3A5 pharmacogenetic testing for tacrolimus in pediatric heart transplant patients: a budget impact analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.